Your browser is no longer supported. Please, upgrade your browser.
Settings
CLSN Celsion Corporation daily Stock Chart
CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-1.29 Insider Own0.40% Shs Outstand18.46M Perf Week4.74%
Market Cap40.80M Forward P/E- EPS next Y-0.94 Insider Trans43.83% Shs Float18.41M Perf Month4.25%
Income-22.00M PEG- EPS next Q-0.36 Inst Own11.40% Short Float5.97% Perf Quarter2.79%
Sales0.50M P/S81.59 EPS this Y77.10% Inst Trans5.73% Short Ratio9.19 Perf Half Y-11.95%
Book/sh0.85 P/B2.60 EPS next Y29.90% ROA-48.50% Target Price9.00 Perf Year0.00%
Cash/sh1.19 P/C1.85 EPS next 5Y- ROE-104.20% 52W Range1.35 - 3.48 Perf YTD56.74%
Dividend- P/FCF- EPS past 5Y43.70% ROI-76.20% 52W High-36.49% Beta2.19
Dividend %- Quick Ratio3.80 Sales past 5Y- Gross Margin- 52W Low63.70% ATR0.13
Employees19 Current Ratio3.80 Sales Q/Q0.00% Oper. Margin- RSI (14)59.22 Volatility5.49% 5.94%
OptionableYes Debt/Eq0.00 EPS Q/Q62.80% Profit Margin- Rel Volume0.44 Prev Close2.18
ShortableYes LT Debt/Eq0.62 EarningsFeb 27 BMO Payout- Avg Volume119.58K Price2.21
Recom1.50 SMA201.82% SMA5014.08% SMA200-9.80% Volume52,856 Change1.38%
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
Feb-01-19 07:30AM  Consolidated Research: 2019 Summary Expectations for Southwest Airlines, Southern Copper, SEI Investments, Forward Air, Cincinnati Financial, and Celsion Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-24-19 11:30AM  Celsion Corporation to Present at NobleConXV Noble Capital Markets 15th Annual Investor Conference GlobeNewswire
Jan-17-19 08:30AM  Celsion Announces Publication of ThermoDox® Study Results in Radiology GlobeNewswire +8.49%
Jan-15-19 08:30AM  Celsion Announces Presentation of GEN-1 Data at Upcoming ASCO-SITC Clinical Immuno-Oncology Symposium GlobeNewswire +6.22%
Dec-25-18 02:47PM  Edited Transcript of CLSN earnings conference call or presentation 15-Nov-18 4:00pm GMT Thomson Reuters StreetEvents
Dec-18-18 08:00AM  Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsions Phase III OPTIMA Study of ThermoDox® for Treatment of Primary Liver Cancer GlobeNewswire -8.33%
Dec-03-18 09:15AM  Celsion Receives $11.1 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program GlobeNewswire
Nov-21-18 02:53PM  Analysts Take Action on Health Care Stocks GuruFocus.com
Nov-14-18 04:30PM  Celsion Corporation Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-08-18 09:15AM  Celsion Corporation to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 15, 2018 GlobeNewswire
Oct-25-18 08:40AM  Report: Exploring Fundamental Drivers Behind The ExOne, Switch, Monotype Imaging, Celsion, TrueCar, and Sandstorm Gold New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-24-18 09:25AM  Celsion Announces Progression-Free Survival Data From GEN-1 Phase I Immuno-Oncology Study of Patients with Stage III/IV Ovarian Cancer GlobeNewswire
Oct-22-18 09:20AM  Celsion Announces Publication Highlighting the Potential of Celsion's Gene-Mediated Immunotherapy to Improve Administration of IL-12 and Progression-Free Survival in Ovarian Cancer Patients GlobeNewswire -8.43%
Oct-03-18 05:15PM  Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Sep-17-18 08:30AM  Celsion Appoints Marianne Lambertson as Vice President of Communications and Investor Relations GlobeNewswire
Sep-16-18 02:22PM  The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Sep-06-18 08:00AM  Celsion Announces First Patient Randomized in the Gene-Mediated Immunotherapy (GEN-1) Study of Newly Diagnosed Stage III/IV Ovarian Cancer Patients GlobeNewswire
Sep-05-18 08:00AM  Celsion Announces Enrollment Completion for Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire -6.42%
07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group New Research Emphasizes Economic Growth GlobeNewswire
Sep-04-18 08:30AM  Celsion Strengthens Its Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for up to $10 Million in Non-Dilutive Funding GlobeNewswire
Aug-30-18 04:07PM  Edited Transcript of CLSN earnings conference call or presentation 14-Aug-18 3:00pm GMT Thomson Reuters StreetEvents
Aug-16-18 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within Celsion, Alpha and Omega Semiconductor, SP Plus, Merrimack Pharmaceuticals, La Jolla Pharmaceutical, and SPX New Research Emphasizes Economic Growth GlobeNewswire
Aug-14-18 09:00AM  Celsion Corporation to Host Earnings Call ACCESSWIRE -9.39%
08:30AM  Celsion Corporation Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Aug-07-18 09:00AM  Celsion Corporation to Hold Second Quarter 2018 Financial Results Conference Call on Tuesday, August 14, 2018 GlobeNewswire
Jul-13-18 07:43AM  Zacks.com highlights: Rosehill Resources, Navios Maritime Partners, AMC Entertainment Holdings, Entercom Communications and Celsion Zacks
Jul-12-18 09:12AM  5 Cheap Breakout Stocks for Formidable Returns Zacks
Jul-10-18 08:00AM  CELSION ANNOUNCES PUBLICATION OF THERMODOX® PHASE I CLINICAL STUDY RESULTS IN THE LANCET ONCOLOGY GlobeNewswire -5.21%
Jun-30-18 05:32PM  The Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus Benzinga
Jun-29-18 09:33AM  Celsion (CLSN) Shares March Higher, Can It Continue? Zacks
09:11AM  4 Biotech Stocks to Bet on in the Second Half of 2018 Zacks
Jun-28-18 08:30AM  Celsion Corporation Announces Strategic Loan Facility GlobeNewswire +5.44%
Jun-25-18 08:00AM  Celsion Corporation to Join Russell Microcap® Index GlobeNewswire
Jun-20-18 08:00AM  Today's Research Reports on Trending Tickers: Celsion and Spark Therapeutics ACCESSWIRE
Jun-06-18 02:10PM  Celsion Corporation (NASDAQ:CLSN): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St.
May-28-18 12:02PM  Best NasdaqGS Growth Companies Simply Wall St.
May-16-18 03:52AM  Edited Transcript of CLSN earnings conference call or presentation 11-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-15-18 07:30AM  Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National CineMedia, and Nu Skin Enterprises Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-11-18 08:00AM  Celsion Corporation Reports First Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
May-08-18 08:00AM  Celsion Corporation to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference GlobeNewswire
May-04-18 09:00AM  Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018 GlobeNewswire
Apr-20-18 07:00AM  Free Post Earnings Research Report: Egalet's Q4 Top-Line Growth Beat Estimates ACCESSWIRE
Apr-12-18 08:00AM  International Liver Congress 2018 Symposium Highlights Celsions ThermoDox® in Treatment of Primary Liver Cancer GlobeNewswire
Apr-09-18 08:30AM  Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsions Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer GlobeNewswire
Mar-27-18 07:16PM  Edited Transcript of CLSN earnings conference call or presentation 27-Mar-18 3:00pm GMT Thomson Reuters StreetEvents
08:30AM  Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
08:00AM  Celsion Corporation to Host Earnings Call ACCESSWIRE
07:18AM  When Will Celsion Corporation (NASDAQ:CLSN) Become Profitable? Simply Wall St.
Mar-20-18 08:30AM  Celsion Corporation to Hold Year-End 2017 Financial Results Conference Call on Tuesday, March 27, 2018 GlobeNewswire
Mar-12-18 08:00AM  Celsion Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Mar-08-18 08:30AM  New Research Coverage Highlights Gastar Exploration, CENTENNIAL RES, Advance Auto Parts, Celsion, Regions Financial, and Abraxas Petroleum Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-05-18 10:15AM  Celsion Announces Ovarian Cancer Expert Presentation at Oppenheimer & Co. Investor Event GlobeNewswire +8.89%
Feb-12-18 08:30AM  Celsion Announces ThermoDox® HEAT Study Presentation at Korean Liver Cancer Associations 12th Annual Scientific Meeting GlobeNewswire
Jan-18-18 08:00AM  Celsion Corporation Provides Corporate Update and 2018 Outlook GlobeNewswire
Jan-05-18 09:42AM  Celsion's Phase I/II Cancer Study Initiation Gets FDA Nod Zacks
Jan-04-18 03:37PM  FDA Win Sends Celsion Corporation (CLSN) Shares Higher InvestorPlace
08:52AM  Zacks.com highlights: Hecla Mining, Cloud Peak Energy, Celsion, QuickLogic and Precision Drilling Zacks
08:49AM  Celsion Corporation (CLSN) Shares on the Rise; Heres Why SmarterAnalyst
08:37AM  Celsion shares rise 20% after FDA clears its ovarian cancer therapy for a phase 1/2 trial MarketWatch
08:00AM  Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer GlobeNewswire
Jan-03-18 09:07AM  5 Breakout Stocks Offering Terrific Returns Zacks
Jan-02-18 11:04AM  ETFs with exposure to Celsion Corp. : January 2, 2018 Capital Cube +5.22%
Dec-22-17 11:35AM  ETFs with exposure to Celsion Corp. : December 22, 2017 Capital Cube
Dec-11-17 01:41PM  ETFs with exposure to Celsion Corp. : December 11, 2017 Capital Cube -7.69%
Nov-30-17 01:38PM  ETFs with exposure to Celsion Corp. : November 30, 2017 Capital Cube -7.85%
Nov-29-17 08:04AM  Celsion Corp. :CLSN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-27-17 08:25AM  Recent Analysis Shows Amazon, Oracle, Whiting Petroleum, Mondelez International, Synergy Resources, and Celsion Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -6.13%
Nov-21-17 08:29AM  Heres Why Celsion Corporation Draws a Vote of Confidence from Oppenheimer SmarterAnalyst +33.64%
Nov-20-17 05:18PM  7 Stock's Moving In Monday's After-Hours Session Benzinga +7.00%
09:30AM  Celsion Corporation (CLSN) Shares Climb on Back of New Findings in Liver Tumours Study SmarterAnalyst
08:00AM  Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, TARDOX Study Protocol in the Journal of Therapeutic Ultrasound GlobeNewswire
Nov-14-17 04:46PM  Edited Transcript of CLSN earnings conference call or presentation 14-Nov-17 4:00pm GMT Thomson Reuters StreetEvents -5.19%
03:29PM  Is It The Right Time To Buy Celsion Corporation (CLSN)? Simply Wall St.
08:10AM  Todays Research Reports on Stocks to Watch: Celsion Corporation and Nektar Therapeutics ACCESSWIRE
08:00AM  Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
07:20AM  Celsion Corporation to Host Earnings Call ACCESSWIRE
Nov-13-17 07:23PM  CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer GlobeNewswire +6.00%
05:15PM  Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer GlobeNewswire
Nov-07-17 10:00AM  ETFs with exposure to Celsion Corp. : November 7, 2017 Capital Cube
09:00AM  Celsion Corporation to Hold Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017 GlobeNewswire
Oct-27-17 09:46AM  Celsion Corporation (CLSN) Spooks Investors with a Share Dilution SmarterAnalyst -19.23%
09:10AM  Celsion Corporation Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock GlobeNewswire
Oct-18-17 08:30AM  Celsion Provides Summary of Research and Development Day Held on October 12, 2017 GlobeNewswire
07:30AM  This Unknown E-Commerce Stock Could Return 300% in 2017 ACCESSWIRE
Oct-17-17 08:30AM  Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017 GlobeNewswire -6.13%
Oct-16-17 08:30AM  Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Cancer Research GlobeNewswire
Oct-12-17 11:03AM  Celsion to Host Research and Development (R&D) Day on Thursday, October 12, 2017 GlobeNewswire -11.82%
Oct-10-17 11:11AM  ETFs with exposure to Celsion Corp. : October 10, 2017 Capital Cube +23.66%
Oct-09-17 10:13AM  Cancer Space Last Week Update: Pipeline Expansion in Focus Zacks +11.04%
Oct-04-17 01:45PM  Celsion Corporation Announces Gross Proceeds of $15.6 Million from the Exercise of Existing Common Stock Warrants GlobeNewswire -37.29%
12:24PM  Celsion's Immunotherapy Candidate Impresses, Stock Surges Zacks
09:00AM  Celsion to Host Research and Development Update October 12, 2017 GlobeNewswire
08:35AM  Updated Outlook and Pipeline Review on Celsion Corporation ACCESSWIRE
08:20AM  Today's Research Reports on Stocks to Watch: Celsion Corporation and Cesca Therapeutics ACCESSWIRE
Oct-03-17 09:00AM  Celsion Announces Final Clinical and Translational Research Data from its OVATION Study at the AACR Special Conference on Ovarian Cancer GlobeNewswire +301.32%
Sep-27-17 09:00AM  Celsion Provides Update on ThermoDox® in the Phase III OPTIMA Study of Primary Liver Cancer GlobeNewswire
Sep-18-17 05:35PM  ETFs with exposure to Celsion Corp. : September 18, 2017 Capital Cube +9.09%
Sep-08-17 08:57AM  Stocks Near 52-Week Lows: 4 Attractive Picks Zacks
Aug-31-17 05:46PM  ETFs with exposure to Celsion Corp. : August 31, 2017 Capital Cube
Aug-24-17 10:47AM  Celsion Corp. :CLSN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Celsion Corporation, a development stage oncology drug company, focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company's lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials to treat recurrent chest wall breast cancer. It is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tardugno Michael HChairman, President and CEOOct 29Buy2.067,50015,48427,700Oct 30 08:38 AM
Hooper Robert WDirectorOct 03Buy2.704,90013,23025,687Oct 03 10:45 AM
Hooper Robert WDirectorOct 02Buy2.705,10013,77020,787Oct 03 10:45 AM
Fritz Frederick J.DirectorSep 20Buy2.702,5006,75014,750Sep 21 09:28 AM
Fritz Frederick J.DirectorSep 20Buy2.702,5006,75018,091Sep 21 09:28 AM
Fritz Frederick J.DirectorAug 15Buy2.412,7506,62812,250Aug 15 02:10 PM
Fritz Frederick J.DirectorAug 15Buy2.372,7506,51815,591Aug 15 02:10 PM
Tardugno Michael HChairman, President and CEOApr 09Buy2.302,5005,75020,200Apr 09 01:14 PM
Tardugno Michael HChairman, President and CEOMar 05Buy2.387,50017,84017,700Mar 05 11:24 AM
Martinez Alberto R JrDirectorFeb 22Buy2.177,14315,50020,000Feb 22 12:09 PM
Fritz Frederick J.DirectorFeb 20Buy2.173,0006,5109,500Feb 21 09:27 AM
Fritz Frederick J.DirectorFeb 20Buy2.173,0006,51012,841Feb 21 09:27 AM
Hooper Robert WDirectorFeb 20Buy2.1813,62529,70315,687Mar 02 04:40 PM